Biotechnology News Nasopharyngeal Search

| Biotechnology feed | All feeds

BioNews
Biotechnology, Pharmaceutical and Life Science News

Search Results

Documents 1-7 out of 7 found

Current Search: nasopharyngeal: 7

[Head and Neck Cancer] Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal C
From the Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Statistics, American College of Radiology, Philadelphia, PA; The University of Texas M.

Anderson Cancer Center, Houston, TX; Image-Guided Therapy Center; and...

Journal of Clinical Oncology: Jul 1 2009 5:52AM
Matching: nasopharyngeal

Find similar documents

The BAHA Hearing System for Hearing-Impaired Postirradiated Nasopharyngeal Cancer Patients: A New Indication
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Otology and Neurotology, 06/24/09 Print Save in My Library Free Abstract Soo G et al.

- Successful osseointegration was demonstrated in postirradiated NPC...

MDLinx: Jun 25 2009 1:05AM
Matching: nasopharyngeal

Find similar documents

Visual Loss Secondary to Orbital Apex Invasion as the First Manifestation of Recurrent Nasopharyngeal Carcinom
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Ophthalmic Plastic and Reconstructive Surgery, 06/05/09 Print Save in My Library Free Abstract Bernardini FP et al.

- Results from an incisional biopsy of...

MDLinx: Jun 6 2009 6:31PM
Matching: nasopharyngeal

Find similar documents

Cyclacel Pharma Reports positive Initial Phase 2 Seliciclib Data in Patients With Nasopharyngeal Carcinoma - q
PM ET RELATED NEWS TOP MARKET NEWS (RTTNews) - Cyclacel Pharmaceuticals Inc.

(CYCC: News ,CYCCP: News ) reported positive interim data from a mid-stage trial of oral sapacitabine, a novel nucleoside analog, in elderly patients with acute...

RTTNews.com: May 29 2009 7:10PM
Matching: nasopharyngeal

Find similar documents

Cyclacel Reports Initial Phase 2 Seliciclib Data in Patients With Nasopharyngeal Carcinoma At 2009 ASCO Annual
(GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc.

today announced interim data from the lead-in stage of a Phase 2 randomized clinical trial of oral seliciclib (CYC202), a novel cyclin dependent kinase (CDK) inhibitor, in patients with...

NewsBlaze: May 29 2009 7:03PM
Matching: nasopharyngeal

Find similar documents

Human metapneumovirus: a new threat?
Dr A Manuel, Respiratory Specialist Registrar, Heatherwood and Wexham Park Hospitals, Berkshire, UK; ari.manuel@hwph-tr.nhs.uk The first 150 words of the full text of this article appear below.

Human metapneumovirus (HMPV) causes illness...

British Journal of the Thorax: May 28 2009 7:46PM
Matching: nasopharyngeal

Find similar documents

Optimization of LMP-specific CTL expansion for potential adoptive immunotherapy in NPC patients
1EBV Biology Laboratory, Division of immunology, Australian Centre for Vaccine Development, The Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Brisbane, Queensland, Australia 2The Cancer Immunology Research...

Immunology and Cell Biology: May 26 2009 11:11AM
Matching: nasopharyngeal

Find similar documents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.